Cargando…
Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients
(1) We investigated the involvement of serum magnesium level in early alcoholic liver disease (ALD), gut barrier dysfunction, and inflammation in alcohol use disorder (AUD) patients; and lastly, the efficacy of 2-week abstinence and medical management to alleviate hypomagnesemia. (2) Forty-eight hea...
Autores principales: | Winrich, Evan J., Gala, Khushboo S., Rajhans, Abhas, Rios-Perez, Christian D., Royer, Amor J., Zamani, Zarlakhta, Parthasarathy, Ranganathan, Marsano-Obando, Luis S., Barve, Ashutosh J., Schwandt, Melanie L., Vatsalya, Vatsalya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569745/ https://www.ncbi.nlm.nih.gov/pubmed/36232646 http://dx.doi.org/10.3390/ijms231911332 |
Ejemplares similares
-
Characterization of Hypomagnesemia in Alcoholic Hepatitis Patients and Its Association with Liver Injury and Severity Markers
por: Winrich, Evan J., et al.
Publicado: (2023) -
Illustration of Gut–Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function
por: Sagaram, Manasa, et al.
Publicado: (2022) -
Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope
por: Gala, Khushboo S., et al.
Publicado: (2020) -
Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis
por: Sagaram, Manasa, et al.
Publicado: (2022) -
Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)